C reactive protein levels are increased in non-allergic but not allergic asthma: a multicentre epidemiological study

Ólafsdottir, I. S.; Gislason, T.; Thjodleifsson, B.; Olafsson, I.; Gislason, D.; Jögi, R. J.; Janson, C.
June 2005
Thorax;Jun2005, Vol. 60 Issue 6, p451
Academic Journal
Background: High sensitivity C reactive protein (HsCRP) is an inflammatory marker known to be related to smoking, obesity, and cardiovascular disease. A study was undertaken to determine whether HsCRP is related to respiratory symptoms, asthma, atopy, and bronchial hyperresponsiveness in population samples from three countries. Methods: HsCRP was measured in 1289 subjects from three centres in ECRHS II: Reykjavik, Uppsala and Tartu. The HsCRP values ranged from <0.01 mg/I to 70.0 mg/I and were divided into four equal groups (⩽0.45, 0.46-0.96, 0.97-2.21, and >2.21 mg/I). Results: HsCRP increased with increasing body mass index (r= 0.41; p<0.0001) and was higher in smokers than in never smokers (p =0.02). A significant relationship was found between increased HsCRP levels and respiratory symptoms such as wheeze, attacks of breathlessness after effort, and nocturnal cough (p<0.0001). The crude odds ratio (95% CI) for the probability of non-allergic asthma was 3.57 (1.83 to 6.96) for subjects in the 4th quartile compared with the 1st quartile of HsCRP. This association remained significant after adjusting for study centre, age, sex, body weight, and smoking history (OR 2.19 (95% CI 1.04 to 4.63)). No significant relationship was observed between HsCRP and allergic asthma or bronchial responsiveness. Conclusions: Raised levels of HsCRP are significantly associated with respiratory symptoms and non- allergic asthma but not with allergic asthma.


Related Articles

  • Systemic inflammation and lung function in young adults. Hancox, Robert J.; Poulton, Richie; Greene, Justina M.; Filsell, Susan; McLachlan, Christene R.; Rasmussen, Finn; Taylor, D. Robin; Williams, Michael J. A.; Williamson, Avis; Malcolm R. Sears // Thorax;Dec2007, Vol. 62 Issue 12, p1064 

    Background: Impaired lung function is associated with systemic inflammation and is a risk factor for cardiovascular disease in older adults. It is unknown when these associations emerge and to what extent they are mediated by smoking, chronic airways disease, and/or established atherosclerosis....

  • Research brief: CRP not a separate heart risk factor.  // GP: General Practitioner;10/14/2005, p5 

    The article presents a study conducted in the U.S. which found that elevated C-reactive protein (CRP) is not an independent risk factor for cardiovascular disease (CVD). Researchers analyzed data from more than 15,000 people. They found that most patients with raised CRP also had another risk...

  • Rosiglitazone Decreases C-Reactive Protein to a Greater Extent Relative to Glyburide and Metformin Over 4 Years Despite Greater Weight Gain. Kahn, Steven E.; Haffner, Steven M.; Viberti, Giancarlo; Herman, William H.; Lachin, John M.; Kravitz, Barbara G.; Yu, Dahong; Paul, Gitanjali; Holman, Rury R.; Zinman, Bernard // Diabetes Care;Jan2010, Vol. 33 Issue 1, p177 

    OBJECTIVE -- C-reactive protein (CRP) is closely associated with obesity and cardiovascular disease in both diabetic and nondiabetic populations. In the short term, commonly prescribed antidiabetic agents have different effects on CRP; however, the long-term effects of those agents are unknown....

  • Obesity Is a Major Determinant of the Association of C-Reactive Protein Levels and the Metabolic Syndrome in Type 2 Diabetes. Kahn, Steven E.; Zinman, Bernard; Haffner, Steven M.; O'Neill, M. Colleen; Kravitz, Barbara G.; Yu, Dahong; Freed, Martin I.; Herman, William H.; Holman, Rury R.; Jones, Nigel P.; Lachin, John M.; Viberti, Giancarlo C. // Diabetes;Aug2006, Vol. 55 Issue 8, p2357 

    The inflammatory factor C-reactive protein (CRP) and the fibrinolytic variables fibrinogen and plasminogen activator-1 (PAI-1) are associated with long-term cardiovascular morbidity. To determine the contribution of body adiposity (BMI), insulin sensitivity (homeostasis model assessment of...

  • Is serum cholesterol a risk factor for asthma? Ramaraju, Karthikeyan; Krishnamurthy, Srikanth; Maamidi, Smrithi; Kaza, Anupama Murthy; Balasubramaniam, Nithilavalli // Lung India; 

    has been recently explored with contradicting results. Clarity on the link between serum cholesterol and asthma may lead to new evolutions in planning management strategies. The objective of our study was to examine the relationship between the serum cholesterol, asthma and its characteristics....

  • Traditional cardiovascular risk factors, inflammation and cardiovascular risk in rheumatoid arthritis. Liao, Katherine P.; Solomon, Daniel H. // Rheumatology;Jan2013, Vol. 52 Issue 1, p45 

    Multiple studies demonstrate an increased cardiovascular (CV) risk associated with RA compared with the general population. While part of this risk appears to be mediated by RA-specific factors, such as long-term inflammation, traditional CV comorbidities also play an important role. We review...

  • Stigmata of death: for kidneys and patients. Ronco, Claudio; Bonventre, Joseph V. // Nephrology Dialysis Transplantation;Oct2014, Vol. 29 Issue 10, p1797 

    No abstract available.

  • Polikistik over sendromunda kardiyovasküler hastalık risk faktörü olarak C-reaktif protein düzeyi ve obezite. Uludağ, Eda Ülkü; Gözükara, İlay; Kucur, Suna Kabil; Keskin, Havva; Kılıç, Halime; Kamalak, Zeynep; Kargılı, Ayşe; Durmaz, Şenay Arıkan // Dicle Medical Journal / Dicle Tip Dergisi;2013, Vol. 40 Issue 3, p426 

    Objective: To investigate the role of C-reactive protein (CRP) level elevation and obesity for the increased cardiovascular disease risk in polycystic ovary syndrome (PCOS). Methods: A hundred and nine patients with PCOS and 30 age matched healthy volunteers with regular menstrual cycle are...

  • Markers of Inflammation and Hemodynamic Measurements in Obesity: Copenhagen City Heart Study. Asferg, Camilla; Jensen, Jan S.; Marott, Jacob L.; Appleyard, Merete; Møgelvang, Rasmus; Jensen, Gorm B.; Jeppesen, Jørgen // American Journal of Hypertension;Apr2009, Vol. 22 Issue 4, p451 

    BackgroundLow-grade chronic inflammation has been proposed to play a major role in the pathogenesis of hypertension. Low-grade chronic inflammation is also closely associated with obesity, an established causative factor in the development of hypertension. The purpose of this study was to...


Read the Article


Sign out of this library

Other Topics